We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Eli Lilly and Co | NYSE:LLY | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 9.14 | 1.26% | 734.01 | 737.45 | 721.00 | 724.00 | 2,009,363 | 00:58:46 |
From Apr 2019 to Apr 2024
Regeneron Pharmaceuticals has produced enough supply of its antibody drug to treat 50,000 patients. "Antibody Drugs Touted by Trump Could Be Next to Get Authorized for Covid-19" at 5:30 a.m. ET, incorrectly said it has enough supply to treat 30,000 patients.
(END) Dow Jones Newswires
October 09, 2020 10:54 ET (14:54 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Eli Lilly Chart |
1 Month Eli Lilly Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
